Design of a Novel Small Peptide Targeted against a Tumor-Specific Receptor
- 28 August 2000
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 275 (2) , 631-636
- https://doi.org/10.1006/bbrc.2000.3347
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII)Biochemical Journal, 1997
- The current status of clinical PET imagingClinical Radiology, 1996
- Isolation of High-affinity Monomeric Human Anti-c-erbB-2 Single chain Fv Using Affinity-driven SelectionJournal of Molecular Biology, 1996
- Purification of the Extracellular Domain of the Epidermal Growth Factor Receptor Produced by Recombinant Baculovirus-Infected Insect Cells in a 10-L ReactorPublished by Springer Nature ,1994
- From Peptide to Non-Peptide. 2. The de Novo Design of Potent, Non-peptidal Inhibitors of Platelet Aggregation Based on a Benzodiazepinedione ScaffoldJournal of the American Chemical Society, 1994
- Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.Radiology, 1993
- Making sense from antisense: A review of experimental data and developing ideas on sense–antisense peptide recognitionJournal of Molecular Recognition, 1992
- Design and recognition properties of a hydropathically complementary peptide to human interleukin 1 βBiochemical Journal, 1992
- Similarity between the corticotropin (ACTH) receptor and a peptide encoded by an RNA that is complementary to ACTH mRNA.Proceedings of the National Academy of Sciences, 1985
- Hydropathic anti-complementarity of amino acids based on the genetic codeBiochemical and Biophysical Research Communications, 1984